# US 2021/0172900 A1 · Method for monitoring the viability of a graft

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0172900 A1
- Document ID: US20210172900A1
- Status: Published application
- Kind: A1
- Application number: 17/047,945
- Filed: 2019-04-15
- Published: 2021-06-10
- Earliest claimed: 2018-04-17
- Assignees: Hemarina
- Applicants: Hemarina
- Inventors: Franck ZAL
- Web page: https://patentgrep.com/patent/US20210172900A1

## CPC

- A01N 1/146: Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving
- G01N 27/409: Oxygen concentration cells
- A01N 1/126: Physiologically active agents, e.g. antioxidants or nutrients
- A01N 1/148: with provisions specially adapted for transporting
- A01N 1/16: Physical preservation processes
- A01N 1/143: for organ perfusion
- G01N 2496/70: Blood gas control solutios containing dissolved oxygen, bicarbonate and the like
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention relates to a method for monitoring the oxygenation of a graft, comprising: a) mixing an organ storage solution preferably with at least one molecule chosen from extracellular hemoglobin from annelids, its globins and its globin protomers, in order to obtain a composition, in a sealed container; b) immersion of the graft in the composition obtained in a); c) the introduction of an oxygen probe in the composition obtained in a), or in the composition of step b); and d) the closure of the hermetic container, steps c) and d) being carried out simultaneously or in any order. It also relates to a method for determining the viability of a graft.

## Claims

### Claim 1

Method of monitoring the oxygenation of a graft, comprising:
a) providing an organ storage solution and mixing the organ storage solution with at least one oxygen carrier, to obtain a composition, in a sealed container,
b) immersing the graft in the composition obtained in step a) to obtain a second composition;
c) introducing an oxygen probe in the composition obtained in a), and/or in the second composition of step b); and
d) hermetically closing the sealed container, steps c) and d) being carried out simultaneously or in any order.

### Claim 2 (depends on 1)

Method according to claim 1, wherein:
the at least one oxygen carrier is an extracellular hemoglobin a globin from annelids or a globin protomer from annelids.

### Claim 3 (depends on 1)

Method according to claim 1, further comprising a step e) of transporting the sealed container to the place of transplantation of the graft to a recipient.

### Claim 4 (depends on 1)

Method according to claim 1, wherein step c) comprises introducing a single oxygen probe in the composition obtained in a), or in the second composition obtained in step b).

### Claim 5 (depends on 1)

Method according to claim 1, wherein the oxygen probe of step c) is a Clark electrode or sensor for measuring dissolved oxygen by optical measurement.

### Claim 6 (depends on 1)

Method according to claim 1, wherein the oxygen probe of step c) comprises a probe head coated with a membrane, the probe head consisting of an electrode composed of a cathode of platinum and with a silver anode immersed in an electrolyte, said membrane being permeable to oxygen but impermeable to water and to ions.

### Claim 7 (depends on 1)

Method according to claim 1, comprising a step e′) of establishing a calibration curve representing the pO2 of the composition obtained in a) in which the graft is immersed, optionally normalized relative to the weight of the graft, as a function of time.

### Claim 8

(canceled)

### Claim 9

Method of determining the viability of a graft comprising:
(i) providing an organ-storage solution with at least one oxygen carrier, in order to obtain a composition, in a sealed container;
(ii) immersing the graft in the composition obtained in (i) to obtain a second composition;
(iii) introducing an oxygen probe in the composition obtained in (i), and/or in the second composition of step (ii);
(iv) closing the sealed container, steps (iii) and (iv) being carried out simultaneously or in any order; then
(v) transporting the sealed container, to the place of transplantation of the graft to a recipient,
vi) during steps ii) to v), monitoring the dissolved oxygen in the second composition, wherein the amount of dissolved oxygen indicates the viability of the graft.

### Claim 10 (depends on 2)

Method according to claim 2, wherein the extracellular hemoglobin of annelids is an extracellular hemoglobin of a Polychete Annelid.

### Claim 11 (depends on 1)

Method according to claim 1, wherein the organ-storage solution is an aqueous solution having a pH between 6.5 and 7.5, comprising salts; sugars; antioxidants; active agents; and, optionally, colloids.

### Claim 12 (depends on 5)

The method of claim 5, wherein the optical measurement is luminescence.

### Claim 13 (depends on 9)

The method of claim 9, wherein the at least one oxygen carrier is an extracellular hemoglobin of annelids, a globin of annelids or a globin protomer of annelids.

### Claim 14 (depends on 10)

The method of claim 10, wherein the Polychete Annelid is of the Arenicolidae family or the Nereididae family.

### Claim 15 (depends on 14)

The method of claim 14, wherein the Arenicolidae family is Arenicola marina.

### Claim 16 (depends on 9)

The method of claim 9, further comprising a step of establishing a calibration curve representing the pO2 of a composition obtained in which the graft is immersed, optionally normalized relative to the weight of the graft, as a function of time.

### Claim 17 (depends on 11)

The method of claim 11, wherein:
the salts include chloride, sulfate, sodium, calcium, magnesium and jarassium;
the sugars include mannitol, raffinose, sucrose, glucose, fructose, lactobionate and gluconate;
the antioxidants include glutathione;
the active agents include xanthine oxidase inhibitors and amino acids; and,
the colloids include hydroxyethyl starch, polyethylene glycol or dextran.

### Claim 18 (depends on 17)

The method of claim 17, wherein
the xanthine oxidase inhibitors include allopurinol and lactates; and
the amino acids include histidine, glutamic acid and tryptophan.
